Christopher B Ehrlich - Net Worth and Insider Trading
Christopher B Ehrlich Net Worth
The estimated net worth of Christopher B Ehrlich is at least $0 dollars as of 2024-11-05. Christopher B Ehrlich is the Director of eFFECTOR Therapeutics Inc and owns about 1,450 shares of eFFECTOR Therapeutics Inc (EFTR) stock worth over $0. Details can be seen in Christopher B Ehrlich's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher B Ehrlich has not made any transactions after 2022-10-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher B Ehrlich
Christopher B Ehrlich Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher B Ehrlich owns 5 companies in total, including Paratek Pharmaceuticals Inc (PRTK) , Tesaro Inc (TSRO) , and Reshape Lifesciences Inc (RSLS) among others .
Click here to see the complete history of Christopher B Ehrlich’s form 4 insider trades.
Insider Ownership Summary of Christopher B Ehrlich
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRTK | Paratek Pharmaceuticals Inc | 2009-01-30 | director |
| TSRO | Tesaro Inc | 2012-07-03 | 10 percent owner |
| RSLS | Reshape Lifesciences Inc | 2007-11-20 | 10 percent owner |
 | | 2022-10-04 | director & 10 percent owner & Chief Executive Officer |
| | 2021-10-05 | director & 10 percent owner & CEO and and Secretary |
Christopher B Ehrlich Latest Holdings Summary
Christopher B Ehrlich currently owns a total of 1 stock. Christopher B Ehrlich owns 1,450 shares of eFFECTOR Therapeutics Inc (EFTR) as of October 4, 2022, with a value of $0.
Latest Holdings of Christopher B Ehrlich
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EFTR | eFFECTOR Therapeutics Inc | 2022-10-04 | 1,450 | 0.00 | 0 |
Holding Weightings of Christopher B Ehrlich
Christopher B Ehrlich Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher B Ehrlich has made a total of 6 transactions in eFFECTOR Therapeutics Inc (EFTR) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in eFFECTOR Therapeutics Inc is the acquisition of 14 shares on October 4, 2022, which cost Christopher B Ehrlich around $197.
Insider Trading History of Christopher B Ehrlich
- 1
Christopher B Ehrlich Trading Performance
GuruFocus tracks the stock performance after each of Christopher B Ehrlich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher B Ehrlich is -34.38%. GuruFocus also compares Christopher B Ehrlich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher B Ehrlich within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher B Ehrlich's insider trading performs compared to the benchmark.
Performance of Christopher B Ehrlich
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.43 | | | | | |
| Relative Return to S&P 500(%) | -7.04 | | | | | |
Christopher B Ehrlich Ownership Network
Ownership Network List of Christopher B Ehrlich
Ownership Network Relation of Christopher B Ehrlich
Christopher B Ehrlich Owned Company Details
What does Paratek Pharmaceuticals Inc do?
Who are the key executives at Paratek Pharmaceuticals Inc?
Christopher B Ehrlich is the director of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .
Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary
Over the past 18 months, Christopher B Ehrlich made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .
In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.
Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Paratek Pharmaceuticals Inc Insider Transactions
Christopher B Ehrlich Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher B Ehrlich. You might contact Christopher B Ehrlich via mailing address: 499 Illinois Street, Suite 200, San Francisco Ca 94158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
